| |
| |
|
| Insider
Information: |
Garner William J |
| Relationship: |
Director |
| City: |
Burlingame |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
21,002,547 |
|
|
Indirect Shares
|
13,788 |
|
|
| Direct
Value |
$203,119 |
|
|
|
Indirect Value
|
$2,174 |
|
|
| Total
Shares |
21,016,335 |
|
|
| Total
Value |
$205,293 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Urigen Pharmaceuticals |
URGP |
Chief Executive Offic... |
2009-03-13 |
18,587,340 |
|
0 |
Premium* |
|
|
Kintara Therapeutics, Inc |
KTRA |
Director |
2015-07-16 |
2,415,207 |
2013-11-26 |
10,000 |
Premium* |
|
|
Inmed Pharmaceuticals Inc. |
INM |
Director |
|
0 |
2020-11-12 |
3,788 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INM |
Inmed Pharmaceuticals Inc... |
Director |
– • – |
2020-11-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,788 |
|
% |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2015-07-16 |
4 |
B |
$0.60 |
$10,000 |
D/D |
16,666 |
2,415,207 |
2.39 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2014-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,388,541 |
2,398,541 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2014-03-18 |
4 |
S |
$1.30 |
$104,000 |
D/D |
(80,000) |
10,000 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2014-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
90,000 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2013-11-26 |
4 |
A |
$0.00 |
$0 |
I/I |
5,000 |
10,000 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2013-09-20 |
4 |
B |
$1.00 |
$5,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-03-13 |
4 |
B |
$0.09 |
$90 |
D/D |
1,000 |
18,587,340 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-03-13 |
4 |
B |
$0.09 |
$90 |
D/D |
1,000 |
18,586,340 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-03-11 |
4 |
B |
$0.09 |
$90 |
D/D |
1,000 |
18,585,340 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-03-05 |
4 |
B |
$0.08 |
$400 |
D/D |
5,000 |
18,584,340 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-02-25 |
4 |
B |
$0.10 |
$100 |
D/D |
1,000 |
18,579,340 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-01-30 |
4 |
B |
$0.13 |
$2,392 |
D/D |
17,800 |
18,578,340 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-01-29 |
4 |
B |
$0.15 |
$2,400 |
D/D |
16,000 |
18,560,540 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-01-27 |
4 |
B |
$0.10 |
$1,200 |
D/D |
10,000 |
18,544,540 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-01-26 |
4 |
B |
$0.17 |
$850 |
D/D |
5,000 |
18,534,540 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-01-21 |
4 |
B |
$0.05 |
$2,160 |
D/D |
48,000 |
18,529,540 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
Chief Executive Officer |
• • • |
2009-01-20 |
4 |
B |
$0.05 |
$225 |
D/D |
5,000 |
18,481,540 |
3.15 |
- |
|
| URGP |
Urigen Pharmaceuticals |
PresidentOfficer |
• • • |
2007-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,476,540 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
